Eric Sievers - 28 Feb 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Reporting relationship: Chief Medical Officer
Issuer ticker: BCAB
Reported as of: 28 Feb 2022
Net transaction value: -$3,596
SEC form: 4
Accepted by SEC: 04 Mar 2022, 16:01:29 UTC
Prior SEC filing: 24 Feb 2022
Next SEC filing: 04 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Christian Vasquez, as Attorney-in-Fact for Eric Sievers

Key filing fact

Eric Sievers filed Form 4 for BioAtla, Inc. (BCAB) on 04 Mar 2022.

Key facts

This page summarizes Eric Sievers's Form 4 filing for BioAtla, Inc. (BCAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2022, 16:01.

Change

Previous filing in this sequence was filed on 24 Feb 2022.
Current net transaction value: -$3,596.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCAB transaction

Common Stock

Tax liability

Transaction value: $3,596
Shares: -555
Change %: -0.62%
Price: $6.48
Shares after: 89,499
Date: 28 Feb 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.